Global mitral valve disease market is estimated to be valued at USD 3.06 Bn in 2025 and is expected to reach USD 5.67 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 9.2% from 2025 to 2032.
To learn more about this report, Request sample copy
Mitral valve disease refers to conditions that affect the mitral valve in the heart. This includes mitral regurgitation, mitral stenosis, and mitral valve prolapse. Increasing geriatric population is one of the key factors contributing to the market growth. The market is witnessing positive growth trends over the forecast period supported by factors such as rising incidence of rheumatic heart diseases and implementation of novel technologies in mitral valve repair and replacement surgeries.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients